A Complicated Case of Vertebral Osteomyelitis by Serratia Marcescens

Osteomyelitis is an infection of the bone and bone marrow that can be caused by an exogenous source or by hematogenous spread. The hematogenous spread of bacteria usually results in bacteremia with subsequent infection of the bone. The most commonly associated pathogen with this type of infection is Staphylococcus aureus, with other gram-negative organisms, such as Pseudomonas aeruginosa, also frequently encountered. The microorganism Serratia marcescens is a rare and infrequently encountered cause of this condition known to cause nosocomial infections. This organism can be notoriously difficult to treat, with resistance to many commonly used antibiotics. The case presented is one of vertebral osteomyelitis in an intravenous drug user caused by Serratia marcescens with subsequent treatment and management of the condition. This case allows for investigation into the continued management of intravenous drug user infections, with the isolation and treatment of less commonly encountered pathogens.

[1]  H. Martins,et al.  Serratia marcescens osteomyelitis in Cushing's disease , 2015, BMJ Case Reports.

[2]  S. Thapa,et al.  Severe Osteomyelitis and Septic Arthritis due to Serratia marcescens in an Immunocompetent Patient , 2015, Case reports in infectious diseases.

[3]  A. Khanna,et al.  Serratia marcescens- a rare opportunistic nosocomial pathogen and measures to limit its spread in hospitalized patients. , 2013, Journal of clinical and diagnostic research : JCDR.

[4]  D. Enoch,et al.  Bacteraemia and subsequent vertebral osteomyelitis: a retrospective review of 125 patients. , 2011, QJM : monthly journal of the Association of Physicians.

[5]  J. Horng,et al.  RssAB-FlhDC-ShlBA as a Major Pathogenesis Pathway in Serratia marcescens , 2010, Infection and Immunity.

[6]  M. Arduino,et al.  Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. , 2009, Archives of internal medicine.

[7]  Choong H. Park,et al.  Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007. , 2008, Clinical therapeutics.

[8]  E. Sadowy,et al.  Molecular Survey of β-Lactamases Conferring Resistance to Newer β-Lactams in Enterobacteriaceae Isolates from Polish Hospitals , 2008, Antimicrobial Agents and Chemotherapy.

[9]  L. McDonald,et al.  A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  V L Yu,et al.  Serratia marcescens: historical perspective and clinical review. , 1979 .